Heterocyclic modulators of lipid synthesis
US-2024400552-A1 · Dec 5, 2024 · US
US2016257677A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016257677-A1 |
| Application number | US-201514878526-A |
| Country | US |
| Kind code | A1 |
| Filing date | Oct 8, 2015 |
| Priority date | Jul 21, 2005 |
| Publication date | Sep 8, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
8-Substituted-2,6-methano-3-benzazocines of general structure are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications.
Opening claim text (preview).
I claim: 1 . A compound of formula: wherein Q is A is (CH 2 ) n , wherein one or more CH 2 may be replaced by —O—, cycloalkyl or CR 1a R 1b ; R 1a and R 1b are chosen independently from hydrogen, halogen, lower alkyl, lower alkoxy and lower alkylthio; is an aryl or heteroaryl residue of one to three rings; R 10 is one or two residues chosen independently from hydrogen, hydroxyl, halogen, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, halo(C 1 -C 6 )alkyl and halo(C 1 -C 6 )alkoxy and (C 1 -C 6 )alkylthio; R 11 is H or is an aryl or heteroaryl residue of one to three rings; A′ is (CH 2 ) m wherein one or more CH 2 may be replaced by —O—, cycloalkyl, —CR 1a R 1b , —C(═O)— or —NH—; R 12 is chosen from hydrogen and lower alkyl; R 15 is one or two residues chosen independently from hydrogen, hydroxyl, halogen, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, halo(C 1 -C 6 )alkyl and halo(C 1 -C 6 )alkoxy and (C 1 -C 6 )alkylthio; m is zero or an integer from 1 to 6; and n is an integer from 1 to 6. 2 . A method of treating a patient suffering from a disease or condition wherein said disease or condition is chosen from the group consisting of pain, pruritis, diarrhea, irritable bowel syndrome, gastrointestinal motility disorder, obesity, respiratory depression, convulsions, coughing, hyperalgesia, dyskinesia and drug addiction comprising administering to said patient a compound of claim 1 or a pharmaceutically acceptable salt thereof.
Related publications grouped by family.
Answers are generated from the same data shown on this page.